Respiratory Syncytial Virus Immunoprophylaxis: Novel Opportunities and a Call for Equity
- Piotr Rzymski; Willis Gwenzi
PMID: 38305000DOI: https://dx.doi.org/10.1002/jmv.29453
Access Resources
About
This article discusses new ways to prevent respiratory syncytial virus (RSV) infections, especially in infants and the elderly. It describes how 2023 was important because of new vaccines and antibodies for RSV. However, these treatments are expensive, making it hard for poorer countries to access them. The article suggests five steps to make RSV prevention fairer: using global aid systems, affordable pricing, including equity in health plans, fair distribution methods, and promoting local production. These actions aim to help those most affected by RSV get the care they need quickly.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.